880-P: Effects of Energy Dosing on Safety and Efficacy in an Open-Label Study of Endoscopic Pulsed Electric Field Induced Electroporation in Type 2 Diabetes (REGENT-1 Trial)DAVID N. O'NEAL, Elif I. Ekinci, Rhys Vaughan et al.|Diabetes|2025Cited by 0
876-P: Pulsed Electric Field–Induced Duodenal Recellularization Impact on Insulin Sensitivity and Beta-Cell Function—Results from REGENT-1, an Open-Label, Prospective Study in Type 2 DiabetesElif I. Ekinci, DAVID N. O'NEAL, Martina Drecogna et al.|Diabetes|2025Cited by 0
892-P: Impact of ReCET Therapy on Continuous Glucose Monitoring (CGM) Metrics in Type 2 Diabetes—Insights from the REGENT-1 TrialDAVID N. O'NEAL, Elif I. Ekinci, Barham K. Abu Dayyeh et al.|Diabetes|2025Cited by 0